Atlas Trials

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

Clinical trial NCT04084483 · COMPLETED

Trial details

NCT number
NCT04084483
Sponsor
Kowa Research Institute, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Dry Eye Disease
Start date
2019-08-04
Primary completion
2020-01-09
Enrollment
238

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.